Literature DB >> 16880449

SMART therapy.

Alan Bell, R Andrew McIvor.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16880449      PMCID： PMC1513407          DOI： 10.1503/cmaj.1060124

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

2.  Long-acting beta2-agonists in asthma: safety concerns.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2005-10-07       Impact factor: 8.262

3.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Authors:  Harold S Nelson; Scott T Weiss; Eugene R Bleecker; Steven W Yancey; Paul M Dorinsky
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

4.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.

Authors:  Paul M O'Byrne; Hans Bisgaard; Philippe P Godard; Massimo Pistolesi; Mona Palmqvist; Yuanjue Zhu; Tommy Ekström; Eric D Bateman
Journal:  Am J Respir Crit Care Med       Date:  2004-10-22       Impact factor: 21.405

5.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

6.  Adult Asthma Consensus Guidelines update 2003.

Authors:  Catherine Lemière; Tony Bai; Meyer Balter; Charles Bayliff; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Andrew Cave; Kenneth Chapman; Robert Cowie; Stephen Coyle; Donald Cockcroft; Francine M Ducharme; Pierre Ernst; Shelagh Finlayson; J Mark FitzGerald; Frederick E Hargreave; Donna Hogg; Alan Kaplan; Harold Kim; Cheryle Kelm; Paul O'Byrne; Malcolm Sears; Andrea White Markham
Journal:  Can Respir J       Date:  2004 May-Jun       Impact factor: 2.409

7.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Authors:  Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.